Elawyers Elawyers
Ohio| Change

In re Spectrum Pharmaceuticals, Inc. Derivative Shareholder Litigation, 2:13-cv-00624-JAD-CWH (2016)

Court: District Court, D. Nevada Number: infdco20160916780 Visitors: 1
Filed: Sep. 09, 2016
Latest Update: Sep. 09, 2016
Summary: JOINT STATUS REPORT IN RESPONSE TO THE ORDER TO SHOW CAUSE DATED SEPTEMBER 2, 2016 JENNIFER A. DORSEY , District Judge . WHEREAS, by Order dated September 2, 2016 (D.E. 26), this Court ordered that "the parties must show cause, in writing, no later than September 13, 2016, why this case should not be dismissed. Failure to show cause will result in the dismissal of these consolidated cases without further notice. " (Emphasis in Order); WHEREAS, beginning on April 11, 2013, three federal
More

JOINT STATUS REPORT IN RESPONSE TO THE ORDER TO SHOW CAUSE DATED SEPTEMBER 2, 2016

WHEREAS, by Order dated September 2, 2016 (D.E. 26), this Court ordered that "the parties must show cause, in writing, no later than September 13, 2016, why this case should not be dismissed. Failure to show cause will result in the dismissal of these consolidated cases without further notice." (Emphasis in Order);

WHEREAS, beginning on April 11, 2013, three federal shareholder derivative complaints were filed in this Court against the individual defendants and nominal defendant Spectrum Pharmaceuticals, Inc.: Fik v. Shrotriya, et al., No. 2:13-cv-00624-JAD-CWH; Watkins v. Shrotriya, et al., No. 2:13-cv-00684-JAD-CWH; and Muenchhagen v. Shrotriya, et al., No. 2:13-cv-00942-JAD-CWH (collectively, the "Derivative Actions"). The Derivative Actions generally allege breaches of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets relating to allegations in the securities class action entitled In re: Spectrum Pharmaceuticals, Inc., Securities Litigation, No. 2:13-cv-00433-LDG-CWH (the "Securities Class Action"), which was pending before the Honorable Lloyd D. George and has now settled;

WHEREAS, on May 15, 2013, the Court entered an Order (the "May 15, 2013 Order") consolidating and staying the first two Derivative Actions pending resolution of the Securities Class Action, but allowing the parties to lift the stay following a final ruling on defendants' motion to dismiss in the Securities Class Action. The Court also appointed the Derivative Plaintiff Timothy J. Fik as Lead Plaintiff, Federman & Sherwood as Lead Counsel, Bailey Kennedy as Liaison Counsel, and restyled the consolidated action as In Re: Spectrum Pharmaceuticals, Inc., Derivative Shareholder Litigation;

WHEREAS, on December 6, 2013, the Court ordered that the third filed action, styled Muenchhagen v. Shrotriya, et al., No. 2:13-cv-00942-JAD-CWH, should also be consolidated and stayed pursuant to the May 15, 2013 Order;

WHEREAS, on August 10, 2015, the Parties participated in a formal mediation before Mr. Jed D. Melnick, Esq. ("Mr. Melnick"), a respected and highly experienced mediator, to assist them in exploring a potential negotiated resolution of the claims in the Derivative Actions. To facilitate a productive mediation, the Parties exchanged a series of letters, information and briefs;

WHEREAS, on November 19, 2015, the parties to the Securities Class Action entered into a stipulation of settlement, which the Court preliminarily approved on January 26, 2016. The Court scheduled a hearing on final approval of the settlement in the Securities Class Action for June 13, 2016. The Court approved the settlement on that day;

WHEREAS, subsequent to the August 2015 mediation, counsel for the Parties hereto have completed substantial communications and arm's-length negotiations in an effort to reach a settlement of the Derivative Actions, including parallel derivative actions pending in Nevada state court;

WHEREAS, the Parties have reached a settlement in principle and are negotiating the issue of attorneys' fees and expenses and developing the necessary written agreements to present the proposed settlement to the Court; and

WHEREAS, the Parties have met and conferred, and therefore:

ACCORDINGLY, the Parties respectfully submit that:

1. The Court should allow the Derivative Actions to remain stayed while the parties finalize the settlement; and

2. The parties shall file a further joint status report on the progress of their efforts to finalize the settlement by Tuesday, October 11, 2016.

ORDER

IT IS SO ORDERED.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer